ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Aztiq-Innobic consortium to buy Alvogen subsidiary for $475m Pharmaceutical-Technology
November 29, 2021A consortium led by Icelandic pharmaceutical investment fund Aztiq and Thailand-based life sciences company Innobic has agreed to acquire all shares of Alvogen Emerging Market Holdings (AEMH) from its current stakeholders for $475m.
Pharma Sources Insight January 2025
